Given that chronic IFN signalling is a central pathogenic factor in both primary Sjogren’s syndrome as well as in SLE, these findings could therefore provide a mechanistic rationale underlying the increased frequency of CD57+ CD4+ CTLs in blood of patients with active IFN responses. This evidence concerns the gene IFNA1 and Sjogren syndrome.